Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NIPTE to study scale-up design spaces and parenteral QbD

This article was originally published in The Gold Sheet

Executive Summary

FDA has awarded two contracts to the National Institute for Pharmaceutical Technology and Education for quality-by-design studies. Under a $1.2 million contract, NIPTE will develop models and methodologies for establishing design spaces that could allow commercial scale-up of three types of unit operations without prior approval from FDA. Under a smaller contract, scientists with universities represented by the non-profit organization will work with counterparts at Baxter, Pfizer and FDA to develop case studies that should help establish a common understanding of QbD for common parenteral manufacturing processes. Both contracts will support guidance development by the Office of Pharmaceutical Sciences in FDA's Center for Drug Evaluation and Research (see "The Gold Sheet," September 2008, pp. 4-5)



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts